Nevada Medicaid and Nevada Check Up News (Fourth Quarter 2025 Provider Newsletter) [Read]

Attention Behavioral Health Providers: Monthly Behavioral Health Training Assistance (BHTA) Webinar Scheduled [See Web Announcement 2009]

Attention All Providers: Requirements on When to Use the National Provider Identifier (NPI) of an Ordering, Prescribing or Referring (OPR) Provider on Claims [Announcement 850]

If you are a Medicaid provider whose revalidation application has not been processed by your termination due date, you will be ineligible to provide services to any Nevada Medicaid or Nevada Check Up recipients, including both Fee-for-Service and Managed Care Organization (MCO) enrolled recipients. See Web Announcement 1265

Enrollment Termination Frequently Asked Questions (FAQs) [Review]

Notifications

NOTIFICATION: Some Provider Flex services will be temporarily unavailable due to scheduled maintenance from 7 p.m. Pacific Time on Friday, March 6, 2026, to 11 a.m. Pacific Time on Saturday, March 7, 2026.

During this time:
  • New enrollment applications cannot be started.
  • Revalidation and Update applications will remain available; and
  • Previously started applications can still be accessed and resumed.

URGENT NOTIFICATION: Update regarding the Electronic Visit Verification (EVV) claims processing error. Nevada Medicaid did not receive some claims from Sandata (Optum) in time for the February 06, 2026 financial cycle. The issue was resolved this week. EVV providers can contact Sandata Technologies at (833) 545-0394 or support@sandata.com for assistance.

Known System Issues-Click HERE

Top 10 Claim Denial Reasons and Resolutions/Workarounds for January 2026 Professional Claims. See Web Announcement 3840.

Top Prior Authorization Denial Reasons for the Fourth Quarter of 2025. See Web Announcement 3830.

Attention Providers Using the Authorization Criteria Function: Results that return prior authorization (PA) requirements are accurate. For results that return “There are no records found based on the search criteria,” there may be a PA requirement if limits have been exceeded. To verify PA requirements, please refer to the Medicaid Services Manual (MSM) Chapter for your service type at dhcfp.nv.gov and the Billing Guide for your provider type at www.medicaid.nv.gov.

Scheduled Site Maintenance

During the scheduled site maintenance window the Provider Web Portal will be unavailable. The table below shows the regularly scheduled maintenance window. All times will be in the Pacific time zone.

Monday - Friday
12:00AM - 12:30AM

Monday
8:00PM - 12:00AM

Notice Date Title
October 2017 For Review at October 19, 2017 Meeting: Dental Response for Tramadol and Codeine
October 2017 For Review at October 19, 2017 Meeting: Antiasthmatic – Monoclonal Antibodies
October 2017 For Review at October 19, 2017 Meeting: Austedo™ (Deutetrabenazine)
October 2017 For Review at October 19, 2017 Meeting: Brineura™ (Cerliponase Alfa)
October 2017 For Review at October 19, 2017 Meeting: Emflaza™ (Deflazacort)
October 2017 For Review at October 19, 2017 Meeting: Ingrezza™ (Valbenazine)
October 2017 For Review at October 19, 2017 Meeting: Xadago® (Safinamide)
July 2017 For Review at July 27, 2017 Meeting: Antiemetics - Delta-9-Tetrahydrocannabinol (THC) Derivatives
July 2017 For Review at July 27, 2017 Meeting: Immunomodulators
July 2017 For Review at July 27, 2017 Meeting: NSAID Gastroprotective Combination Agents and COX-2 Inhibitor
July 2017 For Review at July 27, 2017 Meeting: Opioids, Short Acting
July 2017 For Review at July 27, 2017 Meeting: Tramadol and Related Products
April 2017 For Review at April 27, 2017, Meeting: Atypical Antipsychotics
April 2017 For Review at April 27, 2017, Meeting: Exondys 51 (Agent for Duchenne Muscular Dystrophy)
April 2017 For Review at April 27, 2017, Meeting: Incretin Mimetics & Amylinomimetics
April 2017 For Review at April 27, 2017, Meeting: Spinraza (Nusinersen) (Agent for Spinal Muscular Atrophy)
January 2017 For Review at January 26, 2017, Meeting: Incretin Mimetics & Amylinomimetics
January 2017 For Review at January 26, 2017, Meeting: Lumacaftor/Ivacaftor (Orkambi®)
January 2017 For Review at January 26, 2017, Meeting: Opioid Partial Agonist for Management of Opioid Dependence (Buprenorphine)